Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling Order in Actos Bladder Cancer ... (New York New York (PRWEB) February 24 20...)

Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling Order in Actos Bladder Cancer Litigation

Date:2/24/2013

New York, New York (PRWEB) February 24, 2013

Actos lawsuits continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to a Scheduling Order dated February 19, 2013, the Court has established a Pilot Bellwether Program, which sets up a stream-lined selection process for a minimum of two Pilot Bellwether trials. The Order stipulates that the litigation’s first Pilot Bellwether trial will begin on January 27, 2014, while the second will commence on April 14, 2014. Attorneys for both sides have been directed to nominate five Actos lawsuits each to participate in the Pilot Bellwether Discovery Pool by April 1, 2013.* (In re: Actos Product Liability Litigation, MDL No. 2299)

“The bellwether trials will provide valuable insight into how juries might weigh similar Actos claims. We look forward to this process getting underway,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to individuals who may have been harmed by the medication.

Actos Bladder Cancer Lawsuits
Actos, known generically as pioglitazone, is approved as a treatment for type 2 diabetes. The U.S. Food & Drug Administration (FDA) ordered Takeda Pharmaceuticals to add new warnings to the Actos label in June 2011, after a study found that long-term use of the drug increased the risk for bladder cancer.* Since then, hundreds of people have filed Actos bladder cancer lawsuits alleging long-term use of the drug caused them to develop the disease.

The nation’s first trial involving an Actos bladder cancer lawsuit is now underway in Los Angeles Superior Court. According to a recent report
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
4. Researchers Offer Explanation for Actos Bladder Cancer Risk
5. New Lawsuit alleges Actos caused Bladder Cancer
6. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
11. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP

Post Your Comments:

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay ... life, but some of the changes brought about by ... diabetes. New research has found that people with ... percent higher risk of having a severe low blood ... compared to people with diabetes who aren,t depressed. ...

(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...

(Date:5/21/2013)... The team at Comfort &Harmony™, a leader in nurturing ... a nursing pillow. , Nursing pillows are designed ... , In a nursing pillow, important things to ... Designers at Comfort & Harmony, kept this list in mind ... pillow needs to fit a mom’s body and feel comfortable. ...

(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... and process automation applications for video collaboration, today ... innovative vRating index evaluates key performance metrics related ... have an immediate, aggregated indicator of the performance ... of the Vyopta vAnalytics™ application, the vRating™ delivers ...

(Date:5/21/2013)... MAY 21, 2013 Three major Ohio universities and ... Foundation to establish a new collaborative research program aimed ... The March of Dimes intends to invest $10 million ... March of Dimes Prematurity Research Center -- Ohio Collaborative ... Howse, President of the March of Dimes. "This new ...

Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2 Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3 Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2 Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 2 Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 3 Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 2 Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 3 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3

[0] Depression May Raise Low Blood Sugar Risk in Diabetics [0] Mayo Clinic: How gold nanoparticles can help fight ovarian cancer [0] Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow [0] New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks [0] New multi-million dollar research center aims to solve the mystery of premature birth

... -- A new three-year study finds that a multiple sclerosis drug ... form of MS if it,s given early in patients who appear ... called "interferon beta-1a," is not available in the United States. It ... elsewhere. "While we,ve known it,s beneficial to start MS drugs ...

... have discovered that salicylate, the active ingredient in aspirin, ... protein kinase), a key player in regulating cell growth ... fuel-gauge is switched on by exercise and the commonly ... at McMaster University, the University of Dundee and the ...

... HealthDay Reporter , THURSDAY, April 19 (HealthDay News) -- ... the chronic inflammatory skin disease known as psoriasis than ... researchers found that biologics, which can cost upwards of ... standard drug treatment for psoriasis, methotrexate, but that their ...

... , THURSDAY, April 19 (HealthDay News) -- Most ... of a cancer diagnosis low: Don,t smoke, eat healthy, exercise ... make those choices, and a new report suggests that lawmakers ... those changes easier ones to make. ...

... , THURSDAY, April 19 (HealthDay News) -- Online ... a small new study. This is because scammers not ... them by pretending to have a meaningful connection with them. ... was a significant relationship. The U.K. study included 11 ...

... Scientists have identified 33 genes associated with autism and related ... to be altered in people with schizophrenia. Of the ... the first time, according to the study, which currently appears ... print issue of the journal Cell . "By ...

Cached Medicine News:Health News:Early Use of MS Drug May Cut Likelihood of Progression 2 Health News:McMaster researchers find potential for new uses of old drug 2 Health News:New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds 2 Health News:New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds 3 Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 2 Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 3 Health News:Online Dating Scams Can Take Emotional, Financial Toll 2 Health News:Genes Associated With Autism Also Related to Schizophrenia 2

Early Use of MS Drug May Cut Likelihood of Progression McMaster researchers find potential for new uses of old drug New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds Healthy Lifestyle Choices Could Cut Cancer Rates: Report Online Dating Scams Can Take Emotional, Financial Toll Genes Associated With Autism Also Related to Schizophrenia

(Date:5/21/2013)... 21, 2013 Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...

(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...

(Date:5/21/2013)... YORK , May 21, 2013 /PRNewswire/ ... research report is available in its catalogue: ... Markets and Technologies for Optical Coherence Tomography ... STUDY OBJECTIVES ... this study is to offer synopsis of ...

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)

... Oct. 5, 2011 Reportlinker.com announces ... is available in its catalogue: ... Dermatological Drugs, 7th Edition ... This Kalorama Information report details the ...

... Calif., Oct. 5, 2011 In an independent study ... the University of Texas Health Science Center San Antonio ... to compromised blood flow during reconstructive microsurgery when compared ... study by Dr. Cornejo and colleagues is important as ...

The Market for Prescription Dermatological Drugs, 7th Edition Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Alanine Aminotransferase, Serum or Plasma ALA, Urine Al, Serum Ag (Silver), Urine